ArticleNeuropsychiatric disease and treatment2017

Post-marketing observational program of the effectiveness of fluvoxamine for the treatment of depression in patients with neurological disorders: the FRIENDS study.

Nikolay N Yahno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.